1. Home
  2. MYGN

as 10-03-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Nasdaq

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.

Founded: 1991 Country:
United States
United States
Employees: N/A City: SALT LAKE CITY
Market Cap: 2.2B IPO Year: 1995
Target Price: $28.18 AVG Volume (30 days): 651.3K
Analyst Decision: Buy Number of Analysts: 12
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.78 EPS Growth: N/A
52 Week Low/High: $13.82 - $29.30 Next Earning Date: 11-04-2024
Revenue: $802,200,000 Revenue Growth: 14.78%
Revenue Growth (this year): 13.84% Revenue Growth (next year): 9.57%

MYGN Daily Stock ML Predictions

Stock Insider Trading Activity of Myriad Genetics Inc. (MYGN)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Muzzey Dale MYGN Chief Scientific Officer Sep 11 '24 Sell $26.17 2,100 $54,961.20 108,013
DIAZ PAUL J MYGN President and CEO Sep 11 '24 Sell $26.72 15,000 $400,800.00 977,378
Reitan Colleen F MYGN Director Sep 3 '24 Sell $27.95 46,012 $1,285,851.35 42,533
Ancona Margaret MYGN SVP, Chief of Staff Aug 21 '24 Sell $27.82 11,538 $320,987.16 79,366
Kumar Rashmi MYGN Director Aug 19 '24 Sell $28.01 7,500 $210,075.00 77,392

Share on Social Networks: